Detalles de la búsqueda
1.
Protective Effects of PEP-1-GSTA2 Protein in Hippocampal Neuronal Cell Damage Induced by Oxidative Stress.
Int J Mol Sci
; 24(3)2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769090
2.
PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
Molecules
; 26(11)2021 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34206041
3.
Tat-Biliverdin Reductase A Exerts a Protective Role in Oxidative Stress-Induced Hippocampal Neuronal Cell Damage by Regulating the Apoptosis and MAPK Signaling.
Int J Mol Sci
; 21(8)2020 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32290442
4.
Tat-DJ-1 enhances cell survival by inhibition of oxidative stress, NF-κB and MAPK activation in HepG2 cells.
Biotechnol Lett
; 39(4): 511-521, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28074428
5.
Tat-DJ-1 inhibits oxidative stress-mediated RINm5F cell death through suppression of NF-κB and MAPK activation.
Med Chem Res
; 25(11): 2589-2598, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27818604
6.
Tat-Thioredoxin-like protein 1 attenuates ischemic brain injury by regulation of MAPKs and apoptosis signaling.
BMB Rep
; 56(4): 234-239, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36571143
7.
Protective effects of cell permeable Tat-PIM2 protein on oxidative stress induced dopaminergic neuronal cell death.
Heliyon
; 9(5): e15945, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37223703
8.
Tat-RAN attenuates brain ischemic injury in hippocampal HT-22 cells and ischemia animal model.
Neurochem Int
; 167: 105538, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37207854
9.
Tat-GSTpi Inhibits Dopaminergic Cells against MPP+-Induced Cellular Damage via the Reduction of Oxidative Stress and MAPK Activation.
Biomedicines
; 11(3)2023 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36979816
10.
Protective effect of GK2 fused BLVRA protein against oxidative stress-induced dopaminergic neuronal cell damage.
FEBS J
; 290(11): 2923-2938, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36688733
11.
Pharmacokinetic Comparison of Chitosan-Derived and Biofermentation-Derived Glucosamine in Nutritional Supplement for Bone Health.
Nutrients
; 14(15)2022 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35956389
12.
Utilization of an Intracellular Calcium Mobilization Assay for the Screening of Transduced FK506-Binding Proteins.
Assay Drug Dev Technol
; 19(7): 442-452, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34415786
13.
Tataldose reductase prevents dopaminergic neuronal cell death by inhibiting oxidative stress and MAPK activation.
Int J Mol Med
; 47(2): 751-760, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33416093
14.
Protective Role of Transduced Tat-Thioredoxin1 (Trx1) against Oxidative Stress-Induced Neuronal Cell Death via ASK1-MAPK Signal Pathway.
Biomol Ther (Seoul)
; 29(3): 321-330, 2021 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33436533
15.
Transduced Tat-PRAS40 prevents dopaminergic neuronal cell death through ROS inhibition and interaction with 14-3-3σ protein.
Free Radic Biol Med
; 172: 418-429, 2021 08 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34175438
16.
Tat-thioredoxin 1 reduces inflammation by inhibiting pro-inflammatory cytokines and modulating MAPK signaling.
Exp Ther Med
; 22(6): 1395, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34650643
17.
Tat-indoleamine 2,3-dioxygenase 1 elicits neuroprotective effects on ischemic injury.
BMB Rep
; 53(11): 582-587, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32684242
18.
Tat-CIAPIN1 inhibits hippocampal neuronal cell damage through the MAPK and apoptotic signaling pathways.
Free Radic Biol Med
; 135: 68-78, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30818058
19.
Neuroprotective effects of Tat-ATOX1 protein against MPP+-induced SH-SY5Y cell deaths and in MPTP-induced mouse model of Parkinson's disease.
Biochimie
; 156: 158-168, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30352250
20.
Protective effects of Tat-DJ-1 protein against streptozotocin-induced diabetes in a mice model.
BMB Rep
; 51(7): 362-367, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29936932